Catheterization and Cardiovascular Interventions

Volume 97, Issue 5 pp. 950-954

CASE REPORT

Transcatheter aortic valve implantation for severe pure aortic regurgitation due to active aortitis

Rossella Ruggiero MD,

Rossella Ruggiero MD

orcid.org/0000-0002-4731-9225

University of Ferrara, Ferrara, Italy

Interventional Cardiology Unit, GVM Care and Research Maria Cecilia Hospital, Cotignola, Italy

Search for more papers by this author

Francesco Ponticelli MD,

Francesco Ponticelli MD

orcid.org/0000-0003-0135-5551

Interventional Cardiology Unit, GVM Care and Research Maria Cecilia Hospital, Cotignola, Italy

Search for more papers by this author

Francesco Giannini MD,

Corresponding Author

Francesco Giannini MD

[email protected]

orcid.org/0000-0002-3391-9860

Interventional Cardiology Unit, GVM Care and Research Maria Cecilia Hospital, Cotignola, Italy

Correspondence

Francesco Giannini, MD, Interventional Cardiology Unit, GVM Care and Research Maria Cecilia Hospital, Via Madonna di Genova, 1, 48033 Cotignola RA, Italy.

Email: [email protected]

Search for more papers by this author

Marcello Galvani MD,

Marcello Galvani MD

Unità Operativa di Cardiologia, Ospedale GB Morgagni, Forlì, Italy

Search for more papers by this author

Rossella Ruggiero MD,

Rossella Ruggiero MD

orcid.org/0000-0002-4731-9225

University of Ferrara, Ferrara, Italy

Interventional Cardiology Unit, GVM Care and Research Maria Cecilia Hospital, Cotignola, Italy

Search for more papers by this author

Francesco Ponticelli MD,

Francesco Ponticelli MD

orcid.org/0000-0003-0135-5551

Interventional Cardiology Unit, GVM Care and Research Maria Cecilia Hospital, Cotignola, Italy

Search for more papers by this author

Francesco Giannini MD,

Corresponding Author

Francesco Giannini MD

[email protected]

orcid.org/0000-0002-3391-9860

Interventional Cardiology Unit, GVM Care and Research Maria Cecilia Hospital, Cotignola, Italy

Correspondence

Francesco Giannini, MD, Interventional Cardiology Unit, GVM Care and Research Maria Cecilia Hospital, Via Madonna di Genova, 1, 48033 Cotignola RA, Italy.

Email: [email protected]

Search for more papers by this author

Marcello Galvani MD,

Marcello Galvani MD

Unità Operativa di Cardiologia, Ospedale GB Morgagni, Forlì, Italy

Search for more papers by this author

First published: 31 August 2020

https://doi.org/10.1002/ccd.29249

Share a link

Email
Wechat
Bluesky

Abstract

Aortitis is an uncommon systemic inflammatory disease affecting the aorta and its main branches. Severe aortic regurgitation (AR) represents a fearsome complication of aortitis and is associated with an increased mortality rate. Surgical aortic valve replacement represents the only treatment choice for these patients. However, it is associated with a higher risk of medium to long-term complications such as prosthetic valve detachment. This is the first reported case where severe AR secondary to aortitis was managed with transcatheter aortic valve implantation (TAVI). TAVI was safe and effective in this clinical setting and may be considered a viable alternative to high-risk surgery in these complex patients.

CONFLICT OF INTEREST

The authors report no conflicts of interest.

REFERENCES

1Agueda AF, Monti S, Luqmani RA, et al. Management of Takayasu arteritis: a systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis. RMD Open. 2019; 5(2): 1-13. https://doi.org/10.1136/rmdopen-2019-001020.
10.1136/rmdopen-2019-001020
Web of Science® Google Scholar
2Kaku Y, Aomi S, Tomioka H, Yamazaki K. Surgery for aortic regurgitation and aortic root dilatation in Takayasu arteritis. Asian Cardiovasc Thorac Ann. 2015; 23(8): 901-906. https://doi.org/10.1177/0218492315591291.
10.1177/0218492315591291
CAS PubMed Google Scholar
3Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017; 38(36): 2739-2786. https://doi.org/10.1093/eurheartj/ehx391.
10.1093/eurheartj/ehx391
PubMed Web of Science® Google Scholar
4Comarmond C, Biard L, Lambert M, et al. Long-term outcomes and prognostic factors of complications in Takayasu arteritis: a multicenter study of 318 patients. Circulation. 2017; 136(12): 1114-1122. https://doi.org/10.1161/CIRCULATIONAHA.116.027094.
10.1161/CIRCULATIONAHA.116.027094
PubMed Web of Science® Google Scholar
5Matsuura K, Ogino H, Kobayashi J, et al. Surgical treatment of aortic regurgitation due to takayasu arteritis: long-term morbidity and mortality. Circulation. 2005; 112(24): 3707-3712. https://doi.org/10.1161/CIRCULATIONAHA.105.535724.
10.1161/CIRCULATIONAHA.105.535724
PubMed Web of Science® Google Scholar
6Morton DL, Thompson JF, Cochran AJ, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2014; 370(7): 599-609. https://doi.org/10.1056/NEJMoa1310460.
10.1056/NEJMoa1310460
CAS PubMed Web of Science® Google Scholar
7Rudasill SE, Sanaiha Y, Xing H, et al. Association of autoimmune connective tissue disease and outcomes in patients undergoing transcatheter aortic valve implantation. Am J Cardiol. 2019; 123(10): 1675-1680. https://doi.org/10.1016/j.amjcard.2019.02.023.
10.1016/j.amjcard.2019.02.023
PubMed Web of Science® Google Scholar
8Elbadawi A, Ahmed HMA, Mahmoud K, et al. Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with rheumatoid arthritis (from the Nationwide inpatient database). Am J Cardiol. 2019; 124(7): 1099-1105. https://doi.org/10.1016/j.amjcard.2019.07.009.
10.1016/j.amjcard.2019.07.009
PubMed Web of Science® Google Scholar
9Franzone A, Piccolo R, Siontis GCM, et al. Transcatheter aortic valve replacement for the treatment of pure native aortic valve regurgitation: a systemic review. JACC Cardiovasc Interv. 2016; 9(22): 2308-2317. https://doi.org/10.1016/j.jcin.2016.08.049.
10.1016/j.jcin.2016.08.049
PubMed Web of Science® Google Scholar
10Arias EA, Bhan A, Lim ZY, Mullen M. TAVI for pure native aortic regurgitation: are we there yet? Interv Cardiol Rev. 2019; 14(1): 26-30. https://doi.org/10.15420/icr.2018.37.1.
10.15420/icr.2018.37.1
Google Scholar
11Moreno-Samos JC, Vidovich MI. Device embolization in Transcatheter aortic valve procedures. JACC Case Rep. 2019; 1(2): 105-107. https://doi.org/10.1016/j.jaccas.2019.07.007.
10.1016/j.jaccas.2019.07.007
Google Scholar
12Roy DA, Schaefer U, Guetta V, et al. Transcatheter aortic valve implantation for pure severe native aortic valve regurgitation. J Am Coll Cardiol. 2013; 61(15): 1577-1584. https://doi.org/10.1016/j.jacc.2013.01.018.
10.1016/j.jacc.2013.01.018
PubMed Web of Science® Google Scholar
13Hosoba S, Yamamoto M, Shioda K, et al. Safety and efficacy of minimalist approach in transfemoral transcatheter aortic valve replacement: insights from the Optimized transCathEter vAlvular interventioN-Transcatheter Aortic Valve Implantation (OCEAN-TAVI) registry. Interact Cardiovasc Thorac Surg. 2018; 26(3): 420-424. https://doi.org/10.1093/icvts/ivx355.
10.1093/icvts/ivx355
PubMed Web of Science® Google Scholar
14Patrick A, Calvert P, David B, et al. Percutaneous device closure of paravalvular leak combined experience from the United Kingdom and Ireland. Circulation. 2016; 134(13): 934-944. https://doi.org/10.1161/CIRCULATIONAHA.116.022684.
10.1161/CIRCULATIONAHA.116.022684
PubMed Web of Science® Google Scholar
15Losmanova T, Tosoni I, Fahrni S, Ballmer PE. Autopsy case of aortic dissection after transcatheter aortic valve implantation (TAVI). BMJ Case Rep. 2018; 2018: 1-3. https://doi.org/10.1136/bcr-2017-220105.
Google Scholar

Volume97, Issue5

April 1, 2021

Pages 950-954

SCAI Member Sign in

Transcatheter aortic valve implantation for severe pure aortic regurgitation due to active aortitis

Abstract

CONFLICT OF INTEREST

REFERENCES

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Transcatheter aortic valve implantation for severe pure aortic regurgitation due to active aortitis

Abstract

CONFLICT OF INTEREST

REFERENCES

References

Related

Information